tiprankstipranks
Trending News
More News >

Nanologica Secures First North American Order for Silica-Based Purification Media

Story Highlights
Nanologica Secures First North American Order for Silica-Based Purification Media

Don’t Miss TipRanks’ Half-Year Sale

An announcement from Nanologica AB ( (SE:NICA) ) is now available.

Nanologica AB has secured its first North American order for its silica-based purification media, NLAB Saga®, from a US-based peptide drug manufacturer. This order, valued at approximately SEK 1.3 million, marks a significant entry into the North American market, complementing the company’s existing focus on Asian markets, particularly China. The order will be delivered in the third quarter and represents a strategic expansion for Nanologica, potentially enhancing its market positioning and stakeholder value.

More about Nanologica AB

Nanologica AB is a Swedish life science tools company that specializes in developing, manufacturing, and selling advanced consumables for pharmaceutical manufacturers. Their silica-based products are designed for the purification of peptide drugs, such as insulin and GLP-1 analogues, which help increase productivity and reduce costs for pharmaceutical companies. The company operates in a growing global niche market driven by the rising demand for diabetes and obesity treatments, aiming to enhance access to cost-effective medicines worldwide. Nanologica is headquartered in Södertälje and is listed on the Nasdaq Stockholm Main Market.

Average Trading Volume: 340,449

Current Market Cap: SEK99.84M

See more data about NICA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1